Yu-Chi Lee

3PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 26, 2020
IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis.

David Bauché, Barbara Joyce-Shaikh, Julie Fong

|Mar 20, 2019
Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality.

Govindarajan Thangavelu, Yu-Chi Lee, Michael Loschi

Pageof 1